| Summary of Stock Options Outstanding under Plans |
The table below provides stock option information for the three months ended September 30, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
Weighted-
Average
Exercise
Price Per
Share |
|
Weighted-
Average
Remaining
Contractual
Life |
|
Aggregate
Intrinsic
Value of
In-the-
Money
Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
376,401 |
|
|
$ |
17.68 |
|
|
6.3 years |
|
$ |
4,168 |
|
(1) |
Options exercised |
(10,625 |
) |
|
$ |
12.21 |
|
|
4.5 years |
|
— |
|
|
Options outstanding at end of period |
365,776 |
|
|
$ |
17.84 |
|
|
6.1 years |
|
$ |
4,797 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
348,105 |
|
|
$ |
17.62 |
|
|
6.1 years |
|
$ |
4,641 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $28.45 as of June 30, 2017, over the exercise price, multiplied by the number of options.
|
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $30.95 as of September 30, 2017, over the exercise price, multiplied by the number of options.
|
The table below provides stock option information for the nine months ended September 30, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
Weighted-
Average
Exercise
Price Per
Share |
|
Weighted-
Average
Remaining
Contractual
Life |
|
Aggregate
Intrinsic
Value of
In-the-
Money
Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
387,901 |
|
|
$ |
17.49 |
|
|
6.8 years |
|
$ |
6,752 |
|
(1) |
Options exercised |
(22,125 |
) |
|
$ |
12.19 |
|
|
4.5 years |
|
— |
|
|
Options outstanding at end of period |
365,776 |
|
|
$ |
17.84 |
|
|
6.1 years |
|
$ |
4,797 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
348,105 |
|
|
$ |
17.62 |
|
|
6.1 years |
|
$ |
4,641 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $34.90 as of December 31, 2016, over the exercise price, multiplied by the number of options.
|
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $30.95 as of September 30, 2017, over the exercise price, multiplied by the number of options.
|
|
| Schedule of Restricted Stock Awards |
The table below provides information for restricted stock awards for the three and nine months ended September 30, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, 2017 |
|
Nine Months Ended
September 30, 2017 |
|
Number of
Shares |
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
Number of
Shares
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share
|
Restricted stock at beginning of period |
305,951 |
|
|
$ |
20.21 |
|
|
343,958 |
|
|
$ |
16.60 |
|
Restricted stock granted |
13,173 |
|
|
28.79 |
|
|
104,179 |
|
|
31.04 |
|
Restricted stock vested |
(2,666 |
) |
|
20.52 |
|
|
(122,010 |
) |
|
18.12 |
|
Restricted stock forfeited |
(3,667 |
) |
|
28.60 |
|
|
(13,336 |
) |
|
24.73 |
|
Restricted stock at end of period |
312,791 |
|
|
20.47 |
|
|
312,791 |
|
|
20.47 |
|
|